| The HER-2/neu oncogene in breast cancer: so what is new?. | breast, |
| Prognostic significance of HER-2 oncoprotein expression in breast cancer: a 30-year follow-up. | breast, |
| Expression of Her2/neu oncogene product p185 in correlation to clinicopathological and prognostic factors of gastric carcinoma. | gastric, |
| Differential expression of the neu oncogene in mouse liver and pancreatic cell lines. | pancreatic,liver, |
| Measurement of erbB-2 oncoprotein in human breast cancers by ELISA. | breast, |
| Enzyme-linked immunosorbent assay of c-erbB-2 oncoprotein in breast cancer. | breast, |
| [Interferon-gamma suppresses expression of the HER-2 oncogene in ovarian cancer cells]. | ovarian, |
| Oral cancer progression and c-erbB-2/neu proto-oncogene expression. | oral, |
| c-erbB-2 oncogene in breast cancer: the right target or a decoy?. | breast, |
| Evidence by in situ hybridization that c-erbB-2 proto-oncogene expression is a marker of malignancy and is expressed in lung adenocarcinomas. | lung, |
| Hormonal regulation of c-erbB-2 oncogene expression in breast cancer cells. | breast, |
| Immunolocalization of epidermal growth factor receptor and c-erbB-2 oncogene product in human ovarian carcinoma. | ovarian, |
| HER2 (c-erbB-2) oncoprotein expression in colorectal adenocarcinoma: an immunohistological study using three different antibodies. | colorectal, |
| HER-2/neu oncoprotein as a prognostic factor in breast cancer. | breast, |
| Proliferating cell nuclear antigen in breast lesions: correlation of c-erbB-2 oncoprotein and EGF receptor and its clinicopathological significance in breast cancer. | breast, |
| Prognostic significance of co-expression of c-erbB-2 oncoprotein and epidermal growth factor receptor in breast cancer patients. | breast, |
| Overexpression of the c-erbB-2 oncogene in sarcomas and small round-cell tumors of childhood. An immunohistochemical investigation. | sarcoma, |
| A ligand for the erbB-2 oncogene product (gp30) induces differentiation of human breast cancer cells. | breast, |
| Prognostic factors for recurrent breast cancer: univariate and multivariate analyses including histologic grade and amplification of the c-erbB-2 proto-oncogene. | breast, |
| Sebaceous gland and sweat gland carcinomas of the skin. Clinicopathological study and significance of c-erbB-2 oncoprotein expression. | skin, |